FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Stock

Certificat

DE000JK5DSR5

Real-time Bid/Ask 10:02:08 2024-06-10 am EDT
19.38 EUR / 21.38 EUR -8.36% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-51.64%
1 month+25.23%
Date Price Change
24-06-10 20.53 -7.69%
24-06-07 22.24 -39.12%
24-06-06 36.53 +16.90%
24-06-05 31.25 -10.38%
24-06-04 34.87 +12.41%

Delayed Quote Börse Stuttgart

Last update June 10, 2024 at 06:07 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK5DSR
ISINDE000JK5DSR5
Date issued 2024-03-22
Strike 41.91 $
Maturity Unlimited
Parity 0.35 : 1
Emission price 10.15
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 46.08
Lowest since issue 3.32
Spread 2
Spread %10.29%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
48.85 USD
Average target price
49.93 USD
Spread / Average Target
+2.22%
Consensus